Association Between Proton Pump Inhibitor Use and Cognitive Function in Women
Paul Lochhead1, Kaitlin Hagan2, Amit D Joshi1
1Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts.
Long-term use of proton pump inhibitors (PPIs) showed no convincing link to cognitive decline. This study suggests PPIs do not increase dementia risk, contrary to some prior concerns.
Area of Science:
- Neuroscience
- Pharmacology
- Gerontology
Background:
- Previous studies suggested a link between proton pump inhibitor (PPI) use and dementia.
- Limited data exist on the long-term effects of PPIs on cognitive function.
- H2 receptor antagonists (H2RAs) share clinical indications with PPIs, necessitating a secondary investigation.
Purpose of the Study:
- To investigate the association between long-term proton pump inhibitor (PPI) use and cognitive function.
- To examine the relationship between H2 receptor antagonist (H2RA) use and cognitive performance.
Main Methods:
- Prospective data from 13,864 participants in the Nurses' Health Study II were analyzed.
- Participants completed computerized neuropsychological tests assessing psychomotor speed, attention, learning, working memory, and overall cognition.
- Multivariable linear regression models were employed to assess medication use associations with cognitive scores.
Main Results:
- A modest association was found between longer duration of PPI use (9-14 years) and lower psychomotor speed/attention scores.
- This association was attenuated after controlling for H2RA use.
- Longer duration of H2RA use (9-14 years) was associated with poorer cognitive scores, particularly in learning and working memory, among non-regular PPI users.
Conclusions:
- The study did not find a convincing association between proton pump inhibitor (PPI) use and cognitive function.
- Data do not support the hypothesis that PPI use increases dementia risk.
- Findings for H2 receptor antagonists (H2RAs) require cautious interpretation due to the primary focus on PPIs.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...


